Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
National Cancer Institute (NCI)
PRIMARY OBJECTIVES:
I. The primary objective of this pilot study is to assess the ability of fluorescent imaging and photoacoustic imaging (PAI) in a clinical setting to distinguish benign from malignant tissue.
SECONDARY OBJECTIVES:
I. To qualitatively determine the possible benefit of PAI and fluorescent imaging over traditional white light imaging.
OUTLINE:
Patients undergo fluorescence imaging and PAI during robot assisted laparoscopic surgery.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have a pathologic confirmation of prostate cancer, bladder cancer, or kidney cancer based on previous biopsies or procedures OR a strong concern for a kidney malignancy based on computed tomography (CT) or magnetic resonance imaging (MRI) imaging
Ability to understand and the willingness to sign a written informed consent document
You may not be if
Patients with a surgical history or anatomic variant that would preclude robot assisted laparoscopic approaches to their surgery (i.e. history of ventral hernia repair with mesh)
Patients with medical co-morbidities who cannot tolerate laparoscopic surgery secondary to intra-abdominal carbon dioxide insufflation
Patients with documented allergy or adverse drug reaction to indocyanine green or baseline serum creatinine greater than 1.5 mg/dL
